(1)
Pradelli, L.; Calandriello, M.; Di Virgilio, R.; Bellone, M.; Tubaro, M. Cost‑effectiveness Analysis of Apixaban Versus Other NOACs for the Prevention of Stroke in Italian Atrial Fibrillation Patients. FE 2014, 15, 101-112.